Search results for "Diabetes"
New warnings added on multiple diabetes drugs
This update also covers a risk evaluation and mitigation strategy for liraglutide and approval of a new PCSK9 inhibitor.
https://immattersacp.org/archives/2015/11/fda.htm
1 Nov 2015
ACC pathway supports neprilysin inhibitor, SGLT-2 inhibitors for heart failure with reduced ejection fraction
The American College of Cardiology (ACC) offered this update to their expert consensus decision pathway from 2017 as interim guidance to physicians while comprehensive updates to heart failure guidelines remain in development.
https://immattersacp.org/weekly/archives/2021/01/26/4.htm
26 Jan 2021
New drugs for diabetes, secondary prevention of CV events
This update covers approval of a new drug to treat type 2 diabetes mellitus, along with diet and exercise, and of a drug to reduce risk of heart attack, stroke, cardiovascular death, and need for revascularization in patients with a previous heart attack or peripheral artery disease.
https://immattersacp.org/archives/2014/07/fda.htm
1 Jul 2014
MKSAP Quiz: 6-month history of incontinence
A 68-year-old woman is evaluated for a 6-month history of incontinence typified by continuous leakage and dribbling. Following a physical exam and urinalysis, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2020/12/22/3.htm
22 Dec 2020
New recommendations advise on adding SGLT-2 inhibitors and GLP-1 receptor agonists
A new guideline from The BMJ strongly recommends sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients with diabetes and established cardiovascular and chronic kidney disease, among other advice.
https://immattersacp.org/weekly/archives/2021/05/18/4.htm
18 May 2021
New studies analyze risk factors, treatments for afib
One study found that early rhythm control was better than rate control for low-risk patients, another found that age at menarche and menopause was associated with afib risk, and another indicated that women's lower risk for afib is due to their smaller body size compared with men.
https://immattersacp.org/weekly/archives/2022/09/06/1.htm
6 Sep 2022
Annual face time between patients and physicians rose since 1979 due to longer visits
A racial/ethnic gap in time spent with physicians widened over the three studied decades, with White patients getting 22.9 and 14.7 minutes more per year than Black and Hispanic patients, respectively, by 2018.
https://immattersacp.org/weekly/archives/2022/06/14/1.htm
14 Jun 2022
Getting to know GLP-1 receptor agonists
Choosing among glucagon-like peptide-1 (GLP-1) receptor agonists depends on many factors, such as the desired outcome and individual risks among patients.
https://immattersacp.org/archives/2023/03/getting-to-know-glp-1-receptor-agonists.htm
1 Mar 2023
Canagliflozin may not increase fracture risk in patients at low risk for fractures
Although canagliflozin has been linked to decreased bone mineral density, patients with type 2 diabetes who initiated the drug had similar risk of a first fracture as those who started a glucagon-like peptide-1 receptor agonist.
https://immattersacp.org/weekly/archives/2019/01/08/2.htm
8 Jan 2019
Experts offer optimism on overcoming obesity
ACP and Annals of Internal Medicine hosted a forum on managing the epidemic levels of obesity in America.
https://immattersacp.org/archives/2023/05/experts-offer-optimism-on-overcoming-obesity.htm
1 May 2023